EMR vs NSC

Emerson Electric (EMR) trades at a premium valuation with a current P/E of 31.66, above both its forward P/E of 20.19 and the sector average of 27.54, suggesting some near-term multiple compression risk. Despite solid long-term profitability—evidenced by a 20.72% operating margin and consistent earnings beat streak (22 of last 25 quarters)—recent YoY earnings contraction of -35.3% raises near-term concerns. The stock has underperformed peers over the past year (+1.0% vs. sector momentum), though it shows resilience in dividend policy and maintains a manageable 0.68 debt/equity ratio. Analysts remain constructive with a $151.00 target price implying ~18% upside, but weak insider activity and liquidity metrics temper bullish conviction.

NSC exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9. The stock is severely overvalued, trading at $321.44 despite a Graham Number of $140.92 and an Intrinsic Value of $89.18. This valuation gap is exacerbated by negative year-over-year revenue (-1.70%) and earnings growth (-11.40%), resulting in an unsustainable PEG ratio of 4.12. While operational margins remain strong, the fundamental data suggests the current price is driven by momentum rather than value.